No abstract available
MeSH terms
-
Acute Disease
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers / blood
-
Chronic Disease
-
Graft vs Host Disease / immunology
-
Graft vs Host Disease / mortality
-
Graft vs Host Disease / pathology
-
Graft vs Host Disease / prevention & control*
-
Graft vs Leukemia Effect*
-
HLA Antigens / blood
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Leukemia / therapy
-
Lymphocyte Depletion
-
Lymphoma / therapy
-
Myelodysplastic Syndromes / therapy
-
Severity of Illness Index
-
Sex Factors
-
Stem Cell Transplantation*
-
Survival Rate
-
T-Lymphocytes / drug effects
-
T-Lymphocytes / immunology
-
T-Lymphocytes / pathology
-
Transplantation, Homologous
-
Unrelated Donors
Substances
-
Biomarkers
-
HLA Antigens
-
Immunosuppressive Agents